| Literature DB >> 1778703 |
G Haan1.
Abstract
The decision whether to enhance diffusion and to reimburse for the fertility treatment in-vitro fertilization (IVF) was postponed in the Netherlands until the results of a cost-effectiveness analysis were known. IVF appeared to be as cost-effective as its most important alternative, tubal surgery. But policy decisions still were not straightforward, obscuring important social and ethical issues.Entities:
Mesh:
Year: 1991 PMID: 1778703 DOI: 10.1017/s0266462300007145
Source DB: PubMed Journal: Int J Technol Assess Health Care ISSN: 0266-4623 Impact factor: 2.188